APP and Alzheimer disease: The final modification of the ACH2.0, introduced in the present Perspective, is that AβPP, which is required for the neuronal functionality and viability, is, after all, produced in AD-affected neurons, albeit not conventionally but in an ISR-driven and -compatible process.